Mejia v. Gurvits CA4/2

CourtCalifornia Court of Appeal
DecidedJune 5, 2026
DocketE083293
StatusUnpublished

This text of Mejia v. Gurvits CA4/2 (Mejia v. Gurvits CA4/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mejia v. Gurvits CA4/2, (Cal. Ct. App. 2026).

Opinion

Filed 6/5/26 Mejia v. Gurvits CA4/2

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION TWO

CHONA MEJIA et al.,

Plaintiffs and Appellants, E083293

v. (Super.Ct.No. CVRI2105631)

VADIM GURVITS D.O. et al., OPINION

Defendants and Respondents.

APPEAL from the Superior Court of Riverside County. Erica A. Keen, Judge.

Affirmed.

Chona Mejia and James Mejia, in pro. per., for Plaintiffs and Appellants.

Davis, Grass, Goldstein & Finlay and Gabriel M. Benrubi for Defendants and

Respondents.

1 In this medical malpractice action, plaintiffs Chona and James Mejia appeal from

the summary judgment entered in favor of defendants Vadim Gurvits, D.O.; Abigail

Baker, N.P.; and Britanny Travis, M.A.1 We affirm.

FACTUAL AND PROCEDURAL BACKGROUND

A. Plantiffs’ Lawsuit

Plaintiffs represented themselves in the trial court, as they do on appeal. In the

operative complaint, the Second Amended Complaint (SAC), Chona asserted three

causes of action—(1) medical negligence against all three defendants; (2) medical

negligence against Baker; and (3) negligent hiring and supervision against Dr. Gurvits—

and James asserted a claim for loss of consortium.2

To support her claims, Chona alleged the following: She was a patient of Dr.

Gurvits at his practices of Premier Family Care and Premier Urgent Care from 2018

through April 2021. She suffered from hyperthyroidism, but Dr. Gurvits misdiagnosed

her with hypothyroidism and wrongly prescribed a non FDA-approved medication called

Armour Thyroid to address the misdiagnosed hypothyroidism. Dr. Gurvits first

prescribed the Armour Thyroid medication in June 2019. In August 2019, Dr. Gurvits

instructed Chona to reduce her dosage by half. In February 2020, after she had been

taking the medication for eight months, Dr. Gurvits advised her to stop taking it

1 Because they share a last name, we use the Mejias’ first names when referring to them individually. No disrespect is intended.

2 In response to defendants’ demurrer, the trial court dismissed Chona’s claim of fraud against all three defendants.

2 altogether. For the next 14 months, Chona received no thyroid treatment from Dr.

Gurvits. Then, in May 2021, she saw an endocrinologist who diagnosed her with

“grave[s’] disease/hyperthyroidism” and prescribed the FDA-approved drug

Methimazole.

Chona alleged that Dr. Gurvits was negligent for failing to detect her

hyperthyroidism and prescribing Armour Thyroid, that Baker (Dr. Gurvits’s nurse

practitioner) was negligent for refilling the prescription, and that Travis (Dr. Gurvits’s

medical assistant) was negligent for telling her that “Armour Thyroid is for

hypothyroidism and hyperthyroidism and will go away without treatment.” Chona

alleged that defendants were the “proximate cause” of her “harm, past damages, and

future damages.” She alleged that “if Dr. Gurvits did not abandon my thyroid treatment,

I would have obtained a better result, or as an alternative, if he had timely referred me to

an endocrinologist, this lawsuit would not have been filed.”

To support his claim, James alleged that he “suffered a loss of consortium” due to

“the damage suffered by” Chona.

Plaintiffs did not allege in the SAC the particular damages or injuries the

defendants caused. They alleged: “[We] sent Dr. Gurvits [a] notice of intent and

statement of claims [and were] willing to settle with him and with . . . insurance [but] to

no avail; that is why we filed this lawsuit.”

B. Defendants’ Summary Judgment Motion

Defendants filed a motion for summary judgment, arguing that they did not breach

the standard of care when treating Chona’s thyroid condition and did not cause her to

3 suffer any injuries. Dr. Gurvits, the principal and medical director of Premier Family

Care and Premier Urgent Care, filed a declaration in support of the motion, stating that he

first saw Chona in May 2018 and she became his primary care patient in December 2018.

He explained that he initially prescribed Armour Thyroid for Chona because the “clinical

and laboratory evidence” suggested a hypoactive thyroid, but when “subsequent lab

values . . . showed hyperactive thyroid changes,” he reduced and later stopped the

medication. In support of his plan for treatment, Dr. Gurvits attached to his declaration

Chona’s medical records and his progress notes.

Dr. Gurvits also provided the following summary of Chona’s medical care. She

first visited him on May 29, 2018, at Premier Urgent Care, complaining of neck and

shoulder pain, joint pain that existed off and on for several months, and chronic vertigo

and fatigue. He assessed her with cervical pain and radiculopathy, right rotator cuff

tendonitis, degenerative joint disease of the cervical spine, and fatigue. Her lab studies

revealed that she had uncontrolled type 2 diabetes, as well as what Dr. Gurvits believed

to be “suboptimal” thyroid functioning. Specifically, her “free T3” value was in the low

range (at 3.7), as was her “free T4” value (at 1.4).

In December 2018, when Chona became Dr. Gurvits’s primary care patient, she

completed an intake form and a hormone checklist for women, in which she complained

of mild fatigue, mild memory loss, mild dry and wrinkled skin, moderate hair loss, and

constantly feeling cold. Her next set of lab studies, taken in January 2019, revealed

elevated blood glucose and hemoglobin AIC values, indicating “an ongoing problem with

diabetes.”

4 In May 2019, Chona saw Dr. Gurvits, complaining of heart palpitations, which she

said had been occurring off and on for at least a year, beginning around the same time

that she started menopause. The results of her physical examination, as well as various

heart tests, were normal, but Dr. Gurvits referred her to a cardiologist for additional

assessment.

Chona’s next set of lab studies, taken in June 2019, again indicated suboptimal

thyroid functioning. Her “TSH” level was 1.86, and both her free T3 and free T4 values

were lower than they had been the previous year. (Her free T3 had reduced from 3.7 to

3.2, and her free T4 had reduced from 1.4 to 1.2.) Dr. Gurvits believed that the

“downward trend of the free T3 and free T4,” in combination with her “reported history

of fatigue, memory loss, dry and wrinkled skin, loss of hair, and feeling cold,” indicated

that she had a hypothyroid condition. To address that condition, on June 5, 2019, he

prescribed “Armour Thyroid 1.5 grain (90 mg) with 10 refills.”

In July 2019, Dr. Gurvits referred Chona to a rheumatologist after her lab tests

revealed “positive antinuclear antibodies,” which could indicate an underlying

autoimmune disease.

In August 2019, nurse practitioner Baker approved Chona’s request for additional

refills of Armour Thyroid at 90 mg. The following month, Chona attended a visit,

complaining of dizziness and stomach pain. Her physical examination revealed that she

had lost weight and had low blood pressure. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Biancalana v. T.D. Service Co.
300 P.3d 518 (California Supreme Court, 2013)
Travelers Property Casualty Co. of America v. Superior Court
215 Cal. App. 4th 561 (California Court of Appeal, 2013)
Landeros v. Flood
551 P.2d 389 (California Supreme Court, 1976)
Ballard v. Uribe
715 P.2d 624 (California Supreme Court, 1986)
Denham v. Superior Court
468 P.2d 193 (California Supreme Court, 1970)
Munro v. Regents of University of California
215 Cal. App. 3d 977 (California Court of Appeal, 1989)
Willard v. Hagemeister
121 Cal. App. 3d 406 (California Court of Appeal, 1981)
Jones v. Ortho Pharmaceutical Corp.
163 Cal. App. 3d 396 (California Court of Appeal, 1985)
City of Lincoln v. Barringer
126 Cal. Rptr. 2d 178 (California Court of Appeal, 2002)
Lewis v. County of Sacramento
113 Cal. Rptr. 2d 90 (California Court of Appeal, 2001)
Giacometti v. Aulla, LLC
187 Cal. App. 4th 1133 (California Court of Appeal, 2010)
Aguilar v. Atlantic Richfield Co.
24 P.3d 493 (California Supreme Court, 2001)
Alki Partners, LP v. DB Fund Services, LLC
4 Cal. App. 5th 574 (California Court of Appeal, 2016)
Huang v. Hanks
232 Cal. Rptr. 3d 609 (California Court of Appeals, 5th District, 2018)
Ribakoff v. City of Long Beach
238 Cal. Rptr. 3d 81 (California Court of Appeals, 5th District, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Mejia v. Gurvits CA4/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mejia-v-gurvits-ca42-calctapp-2026.